23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Thermo Fisher Scientific Inc. › 2025-2026

Thermo Fisher Scientific Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Thermo Fisher Scientific Inc.’s Form 8-K, filed May 26, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 13Ballot items
  • 1,645Asset managers, any item
  • 18,377Fund votes
  • May 20, 2026Meeting date

Results at a glance

Meeting of May 20, 2026: 13 items on Thermo Fisher Scientific Inc.’s Form 8-K, filed May 26, 2026: 11 elected · 1 approved · 1 not approved.

Not approved or not elected

Dissent

Notable dissent: 1 director (10.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Thermo Fisher Scientific Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Thermo Fisher Scientific Inc.

These tallies are Thermo Fisher Scientific Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 26, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Thermo Fisher Scientific Inc. — official shareholder meeting results, meeting held May 20, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Marc N. Casper 294,015,47820,501,6401,202,257 ---- 93%Elected—
Elect Director: Nelson J. Chai 293,142,24121,615,744961,390 ---- 93%Elected—
Elect Director: Ruby R. Chandy 312,259,3742,490,403969,598 ---- 99.2%Elected—
Elect Director: C. Martin Harris 285,543,74028,753,0641,422,571 ---- 91%Elected—
Elect Director: Tyler Jacks 304,372,35710,373,697973,321 ---- 97%Elected—
Elect Director: Jennifer M. Johnson 304,583,44310,151,215984,717 ---- 97%Elected—
Elect Director: R. Alexandra Keith 308,290,3116,269,8241,159,240 ---- 98%Elected—
Elect Director: Karen S. Lynch 308,933,0715,811,374974,930 ---- 98%Elected—
Elect Director: Debora L. Spar 314,426,121311,821981,433 ---- 99.9%Elected—
Elect Director: Scott M. Sperling 292,218,75422,524,675975,946 ---- 93%Elected—
Elect Director: Dion J. Weisler 281,791,65632,960,105967,614 ---- 90%Elected—
2. Non-binding, advisory proposal on the compensation of the Company's named executive officers 99,928,178214,525,6731,265,524 ---- 32%Not approved—
3. Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 296,866,70936,064,900999,237 ---- 89%Approved—

Source: Thermo Fisher Scientific Inc., Form 8-K, filed with the SEC on May 26, 2026 — read the filing on EDGAR.

How asset managers voted at the Thermo Fisher Scientific Inc. 2025-2026 meeting

1,645 asset managers disclosed a vote on at least one Thermo Fisher Scientific Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Marc N. Casper

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 294,015,478AGAINST: 20,501,640

Prior year: 91.8% for (May 21, 2025 meeting) ▲ 1.7 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Marc N. Casper

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Marc N. Casper”): 294,015,478 for, 20,501,640 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,985,274 for, 15,583 against, 13,131 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,985,274AGAINST: 15,583ABSTAIN: 13,131NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Marc N. Casper” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,651261 60For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,67530 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Nelson J. Chai

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 293,142,241AGAINST: 21,615,744

Prior year: 94.2% for (May 21, 2025 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Nelson J. Chai

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Nelson J. Chai”): 293,142,241 for, 21,615,744 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,492,133 for, 514,478 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,492,133AGAINST: 514,478ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Nelson J. Chai” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,665251 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,65253 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Ruby R. Chandy

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 312,259,374AGAINST: 2,490,403

Prior year: 99.2% for (May 21, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Ruby R. Chandy

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Ruby R. Chandy”): 312,259,374 for, 2,490,403 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,991,291 for, 15,317 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,991,291AGAINST: 15,317ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Ruby R. Chandy” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,88925 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,7050 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: C. Martin Harris

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 285,543,740AGAINST: 28,753,064

Prior year: 94.2% for (May 21, 2025 meeting) ▼ 3.3 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: C. Martin Harris

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: C. Martin Harris”): 285,543,740 for, 28,753,064 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,468,188 for, 538,417 against, 7,384 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,468,188AGAINST: 538,417ABSTAIN: 7,384NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: C. Martin Harris” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,555355 90For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,65253 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Tyler Jacks

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 304,372,357AGAINST: 10,373,697

Prior year: 98.1% for (May 21, 2025 meeting) ▼ 1.4 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Tyler Jacks

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Tyler Jacks”): 304,372,357 for, 10,373,697 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,935,175 for, 71,435 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,935,175AGAINST: 71,435ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Tyler Jacks” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,780135 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,67530 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Jennifer M. Johnson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 304,583,443AGAINST: 10,151,215

Prior year: 97.9% for (May 21, 2025 meeting) ▼ 1.1 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Jennifer M. Johnson

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Jennifer M. Johnson”): 304,583,443 for, 10,151,215 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,294,309 for, 712,301 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,294,309AGAINST: 712,301ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Jennifer M. Johnson” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,571,94530,971 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,304,1881,286 00For
State Street4,399,7050 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: R. Alexandra Keith

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 308,290,311AGAINST: 6,269,824

Prior year: 98.1% for (May 21, 2025 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: R. Alexandra Keith

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: R. Alexandra Keith”): 308,290,311 for, 6,269,824 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,485,758 for, 520,848 against, 7,381 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,485,758AGAINST: 520,848ABSTAIN: 7,381NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: R. Alexandra Keith” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,85161 60For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,7050 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Karen S. Lynch

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 308,933,071AGAINST: 5,811,374

Prior year: 99.9% for (May 21, 2025 meeting) ▼ 1.8 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Karen S. Lynch

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Karen S. Lynch”): 308,933,071 for, 5,811,374 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,937,288 for, 69,321 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,937,288AGAINST: 69,321ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Karen S. Lynch” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,86154 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,7050 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Debora L. Spar

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 314,426,121AGAINST: 311,821

Prior year: 99.9% for (May 21, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Debora L. Spar

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Debora L. Spar”): 314,426,121 for, 311,821 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,991,313 for, 15,296 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,991,313AGAINST: 15,296ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Debora L. Spar” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,9114 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,7050 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Scott M. Sperling

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 292,218,754AGAINST: 22,524,675

Prior year: 94.3% for (May 21, 2025 meeting) ▼ 1.5 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Scott M. Sperling

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Scott M. Sperling”): 292,218,754 for, 22,524,675 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 111,208,472 for, 798,138 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 111,208,472AGAINST: 798,138ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Scott M. Sperling” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,639276 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,65253 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National624,45998,857 00Mixed
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Elect Director: Dion J. Weisler

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 281,791,656AGAINST: 32,960,105

Prior year: 86.9% for (May 21, 2025 meeting) ▲ 2.6 pts

Details: description as filed, official tally, votes by 263 asset managers

Description as filed by funds: Election of Directors: Dion J. Weisler

Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Dion J. Weisler”): 281,791,656 for, 32,960,105 against, per its Form 8-K filed May 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 263 asset managers below reported 107,830,084 for, 4,176,526 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 107,830,084AGAINST: 4,176,526ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Election of Directors: Dion J. Weisler” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,602,545371 40For
Fidelity14,688,192114,486 00For
Capital Group11,592,3210 00For
BlackRock9,305,4740 00For
State Street4,399,7050 00For
T. Rowe Price3,874,4310 00For
Charles Schwab3,1552,856,374 00Against
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus1,318,7300 00For
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust418,922156,388 00Mixed
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 263 asset managers. All 263 are in the interactive database (link above).

Non-binding, advisory proposal on the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not approved

Combines 33 wordings of this item as funds reported it.

32% Not approved · of votes cast

FOR 32%AGAINST
FOR: 99,928,178AGAINST: 214,525,673

Prior year: 35.5% for (May 21, 2025 meeting) ▼ 3.8 pts

Details: description as filed, official tally, votes by 1,645 asset managers

Description as filed by funds: An advisory vote to approve named executive officer compensation.

Thermo Fisher Scientific Inc.’s own tally for this item (“2. A non-binding, advisory proposal on the compensation of the Company's named executive officers”): 99,928,178 for, 214,525,673 against — failed, per its Form 8-K filed May 26, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “A non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved.”
Support: 32% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 247 asset managers voting on “An advisory vote to approve named executive officer compensation.” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,948,53431,654,379 50Mixed
Fidelity14,647,828154,850 00For
Capital Group3,561,7938,030,528 00Mixed
BlackRock8,352,662952,812 00Mixed
State Street8,7724,390,933 00Against
T. Rowe Price3,753,876120,555 00For
Charles Schwab2,3202,857,209 00Against
Putnam02,707,840 00Against
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco01,372,576 00Against
INVESTMENT CO OF AMERICA01,350,851 00Against
Parnassus01,318,730 00Against
Dimensional0977,778 00Against
JPMorgan887,5540 00For
AMCAP FUND0797,341 00Against
GMO762,1230 00For
Legg Mason0751,930 00Against
Jackson National97,629625,687 00Mixed
Columbia Threadneedle0719,980 00Against
John Hancock456,781137,587 00Mixed
Bridge Builder Trust65,036510,274 00Mixed
MASTER INVESTMENT PORTFOLIO569,1045,516 00For
FRANKLIN MUTUAL SERIES FUNDS0541,772 00Against

Fund voting reports, all 247 managers: 43,017,846 for, 68,730,396 against, 7,554 abstained, 1,217 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1,436 asset managers voting on “An advisory vote to approve named executive officer compensation.” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock14,155,5332,599,362 00Mixed
Capital Group3,942,0326,774,324 320Mixed
State Street59,04510,644,086 00Against
Fidelity8,708,842512,464 00Mixed
GEODE CAPITAL MANAGEMENT, LLC8,375,4380 00For
T. Rowe Price6,944,184147,814 00For
Capital Research Global Investors04,408,936 00Against
Putnam18,9204,034,448 00Against
Vanguard9593,805,351 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3,700,98817,160 00For
Northern Trust02,946,419 00Against
Charles Schwab2,3202,922,824 00Against
Fisher Asset Management, LLC02,669,460 00Against
1832 Asset Management L.P.803,9081,689,392 00Mixed
Union Investment Management GmbH02,375,722 00Against
Grantham, Mayo, Van Otterloo & Co. LLC2,258,2960 00For
Invesco862,208,085 00Against
Unisphere Establishment2,060,0000 00For
Goldman Sachs2,025,5960 00For
AllianceBernstein02,000,167 00Against
PRIMECAP MANAGEMENT CO/CA/1,979,6460 00For
APG Asset Management US Inc.01,962,090 00Against
EdgePoint Investment Group Inc.1,897,0660 00For
MELLON INVESTMENTS Corp01,865,853 00Against
Amundi01,803,115 00Against

Institutional-manager reports, all 1,436 managers: 77,523,843 for, 140,568,510 against, 785,076 abstained, 123,962 not voted, 392 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

89% Approved · of votes cast

FOR 89%
FOR: 296,866,709AGAINST: 36,064,900
Details: description as filed, official tally, votes by 265 asset managers

Description as filed by funds: Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026.

Thermo Fisher Scientific Inc.’s own tally for this item (“3. Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026”): 296,866,709 for, 36,064,900 against — passed, per its Form 8-K filed May 26, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified.”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 265 asset managers below reported 110,150,786 for, 1,871,155 against, 7,379 abstained, 317 not voted, 283 unknown.

FOR
FOR: 110,150,786AGAINST: 1,871,155ABSTAIN: 7,379NOT VOTED: 317UNKNOWN: 283
Largest asset managers voting on “Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent aud” at Thermo Fisher Scientific Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard33,453,651149,265 40For
Fidelity14,802,6780 00For
Capital Group11,592,3210 00For
BlackRock9,296,9498,525 00For
State Street4,391,6268,079 00For
T. Rowe Price3,874,4310 00For
Charles Schwab2,859,5290 00For
Putnam2,707,8400 00For
Six Circles Trust1,893,7260 00For
MFS1,551,9940 00For
TIAA1,524,8320 00For
Invesco1,372,5760 00For
INVESTMENT CO OF AMERICA1,350,8510 00For
Parnassus01,318,730 00Against
Dimensional977,7780 00For
JPMorgan887,5540 00For
AMCAP FUND797,3410 00For
GMO762,1230 00For
Legg Mason751,9300 00For
Jackson National723,3160 00For
Columbia Threadneedle719,9800 00For
John Hancock594,3680 00For
Bridge Builder Trust575,3100 00For
MASTER INVESTMENT PORTFOLIO574,6200 00For
FRANKLIN MUTUAL SERIES FUNDS541,7720 00For

Showing the 25 largest of 265 asset managers. All 265 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of May 22, 2024, which belongs to the 2023-2024 season; 1 item from the meeting of May 21, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest Thermo Fisher Scientific Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 371,621,465 shares outstanding at the time of that meeting.

Fund voting reports: top Thermo Fisher Scientific Inc. shareholders by shares voted on “An advisory vote to approve named executive officer compensation.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 9.04%
2Fidelity 3.98%
3Capital Group 3.12%
4BlackRock 2.50%
5State Street 1.18%
6T. Rowe Price 1.04%
7Charles Schwab 0.77%
8Putnam 0.73%
9Six Circles Trust 0.51%
10MFS 0.42%
Institutional-manager reports: top Thermo Fisher Scientific Inc. shareholders by shares voted on “An advisory vote to approve named executive officer compensation.”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 4.51%
2Capital Group 2.88%
3State Street 2.88%
4Fidelity 2.48%
5GEODE CAPITAL MANAGEMENT, LLC 2.25%
6T. Rowe Price 1.91%
7Capital Research Global Investors 1.19%
8Putnam 1.09%
9Vanguard 1.02%
10MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.00%

Reported Thermo Fisher Scientific Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Thermo Fisher Scientific Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group34,133,702 9.19%Form 13F, quarter ended March 31, 2026
BlackRock30,450,692 8.19%Form 13F, quarter ended March 31, 2026
State Street16,731,668 4.50%Form 13F, quarter ended March 31, 2026
Morgan Stanley11,894,277 3.20%Form 13F, quarter ended March 31, 2026
FMR (Fidelity)10,776,436 2.90%Form 13F, quarter ended March 31, 2026
Franklin Templeton6,813,031 1.83%Form 13F, quarter ended March 31, 2026
JPMorgan Chase6,795,482 1.83%Form 13F, quarter ended March 31, 2026
T. Rowe Price6,315,471 1.70%Form 13F, quarter ended March 31, 2026
Marc N. Casper116,779 0.03%Proxy statement (DEF 14A), table as of February 28, 2026
Michel Lagarde77,390 0.02%Proxy statement (DEF 14A), table as of February 28, 2026

Percentages above are of 371,621,465 shares outstanding, as reported by Thermo Fisher Scientific Inc. on its Form 10-Q dated March 28, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Thermo Fisher Scientific Inc.'s shareholder meeting held May 20, 2026, in the 2025-2026 proxy season, 1,645 asset managers reported votes on at least one of its 13 ballot items in their SEC Form N-PX filings, covering 18,377 separate fund positions. On the most widely held item on that ballot — An advisory vote to approve named executive officer compensation. — Thermo Fisher Scientific Inc.'s filing reports the proposal as not approved, with 32% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Thermo Fisher Scientific Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 26, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Thermo Fisher Scientific Inc.’s 10-Q dated March 28, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Thermo Fisher Scientific Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Thermo Fisher Scientific (TMO) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/thermo-fisher-scientific-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.